Christopher J. Lindop, CFO & EVP Business Development at HAEMONETICS CORP (HAE), bought 412 shares at $32.73 ($13K) on 2013-04-30, disclosed to the SEC on 2013-05-02.
Seasonal purchase ($13k) by CFO & EVP Business Development — this insider has traded HAE in April in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| HAE | SELL | 2015-08-24 | $189K | — | Filing → |
| HAE | SELL | 2015-07-21 | $192K | — | Filing → |
| HAE | SELL | 2015-06-23 | $208K | — | Filing → |